Literature DB >> 23220584

Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate.

Anna Vilà-Brau1, Ana Luísa De Sousa-Coelho, Joana F Gonçalves, Diego Haro, Pedro F Marrero.   

Abstract

FSP27 [cell death-inducing DFFA-like effector c (CIDEC) in humans] is a protein associated with lipid droplets that downregulates the fatty acid oxidation (FAO) rate when it is overexpressed. However, little is known about its physiological role in liver. Here, we show that fasting regulates liver expression of Fsp27 in a time-dependent manner. Thus, during the initial stages of fasting, a maximal induction of 800-fold was achieved, whereas during the later phase of fasting, Fsp27 expression decreased. The early response to fasting can be explained by a canonical PKA-CREB-CRTC2 signaling pathway because: i) CIDEC expression was induced by forskolin, ii) Fsp27 promoter activity was increased by CREB, and iii) Fsp27 expression was upregulated in the liver of Sirt1 knockout animals. Interestingly, pharmacological (etomoxir) or genetic (Hmgcs2 interference) inhibition of the FAO rate increases the in vivo expression of Fsp27 during fasting. Similarly, CIDEC expression was upregulated in HepG2 cells by either etomoxir or HMGCS2 interference. Our data indicate that there is a kinetic mechanism of autoregulation between short- and long-term fasting, by which free FAs delivered to the liver during early fasting are accumulated/exported by FSP27/CIDEC, whereas over longer periods of fasting, they are degraded in the mitochondria through the carnitine palmitoyl transferase system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220584      PMCID: PMC3617935          DOI: 10.1194/jlr.M028472

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  31 in total

1.  Lipid metabolism during fasting.

Authors:  M D Jensen; K Ekberg; B R Landau
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-10       Impact factor: 4.310

2.  Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans.

Authors:  S C Kalhan; S Mahajan; E Burkett; L Reshef; R W Hanson
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

Review 3.  Glyceroneogenesis and the triglyceride/fatty acid cycle.

Authors:  Lea Reshef; Yael Olswang; Hanoch Cassuto; Barak Blum; Colleen M Croniger; Satish C Kalhan; Shirley M Tilghman; Richard W Hanson
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

Review 4.  Glyceroneogenesis revisited.

Authors:  Richard W Hanson; Lea Reshef
Journal:  Biochimie       Date:  2003-12       Impact factor: 4.079

5.  Intracellular localization of the 3-hydroxy-3-methylglutaryl coenzme A cycle enzymes in liver. Separate cytoplasmic and mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A generating systems for cholesterogenesis and ketogenesis.

Authors:  K D Clinkenbeard; W D Reed; R A Mooney; M D Lane
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

6.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

Authors:  Songtao Yu; Kimihiko Matsusue; Papreddy Kashireddy; Wen-Qing Cao; Vaishalee Yeldandi; Anjana V Yeldandi; M Sambasiva Rao; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

7.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors.

Authors:  P E Declercq; J R Falck; M Kuwajima; H Tyminski; D W Foster; J D McGarry
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

Review 8.  Regulation of hepatic fatty acid oxidation and ketone body production.

Authors:  J D McGarry; D W Foster
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

9.  Assay of peroxisomal beta-oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

10.  Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.

Authors:  K Ratheiser; B Schneeweiss; W Waldhäusl; P Fasching; A Korn; P Nowotny; M Rohac; H P Wolf
Journal:  Metabolism       Date:  1991-11       Impact factor: 8.694

View more
  18 in total

1.  Fasting regulates FSP27 expression in the liver.

Authors:  Vishwajeet Puri
Journal:  J Lipid Res       Date:  2013-01-18       Impact factor: 5.922

2.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

3.  Regulation of FSP27 protein stability by AMPK and HSC70.

Authors:  Xiaodong Zhang; Bradlee L Heckmann; Xitao Xie; Alicia M Saarinen; Jun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

4.  Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis.

Authors:  Judith Simcox; Gisela Geoghegan; John Alan Maschek; Claire L Bensard; Marzia Pasquali; Ren Miao; Sanghoon Lee; Lei Jiang; Ian Huck; Erin E Kershaw; Anthony J Donato; Udayan Apte; Nicola Longo; Jared Rutter; Renate Schreiber; Rudolf Zechner; James Cox; Claudio J Villanueva
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

5.  Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasis.

Authors:  Michele Campaigne Larsen; Justin R Bushkofsky; Tyler Gorman; Vaqar Adhami; Hasan Mukhtar; Suqing Wang; Scott B Reeder; Nader Sheibani; Colin R Jefcoate
Journal:  Arch Biochem Biophys       Date:  2015-02-20       Impact factor: 4.013

6.  CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis.

Authors:  Cédric Langhi; Ángel Baldán
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

7.  Insulin Represses Fasting-Induced Expression of Hepatic Fat-Specific Protein 27.

Authors:  Kohei Matsuo; Kimihiko Matsusue; Daisuke Aibara; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2017       Impact factor: 2.233

Review 8.  Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC.

Authors:  Suthat Liangpunsakul; Bin Gao
Journal:  J Investig Med       Date:  2016-06-24       Impact factor: 2.895

9.  Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes.

Authors:  Wenyi Xu; Lizhen Wu; Miao Yu; Feng-Jung Chen; Muhammad Arshad; Xiayu Xia; Hao Ren; Jinhai Yu; Li Xu; Dijin Xu; John Zhong Li; Peng Li; Linkang Zhou
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

10.  Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver.

Authors:  Daisuke Aibara; Kimihiko Matsusue; Kohei Matsuo; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.